Conference Call Events

[panguluri]

Eventsurvey360 is a platform used to the create the events and conduct the conference.conference calls are nothing but a telephone call where all the members involve in the calls and listen to the one person what he is saying. Event calls means discussing the things related to the event.There are many platforms to create the events,eventsurvey360 provide all the features that are available in market.Conference calls are allowing the other participants into the call by providing them the conference code.

To know more : https://www.eventsurvey360.com/

[ECole]

FCEL earnings call updates

The company owns approximately 46,000 megawatts of power generation and service over 2 million retail customers


http://www.earningsimpact.com/Transcript/83444/FCEL/FuelCell-Energy%2c-Inc----Q3-2013-Earnings-Call

[ECole]

Kipp Bedard in conversation with Citi's Glen Yeung @ Citi 2013 Global Technology Conference.



http://www.earningsimpact.com/Transcript/83397/MU/Micron-Technology%2c-Inc----Citi-2013-Global-Technology-Conference

[ECole]

Halozyme Therapeutics (HALO)- Market share for our first FDA approved product Hylenex in the United States of America Exceeds 50% in a market with approximately 20 million in annual revenues




http://www.earningsimpact.com/Transcript/82682/HALO/Halozyme-Therapeutics%2c-Inc----Q2-2013-Earnings-Call

[ECole]

Tesla Live Event 2013

Its like Apple's worldwide Developers Conference. You should see Elon's remarks.. I hv become a fan of Elon

http://www.earningsimpact.com/Transcript/83311/TSLA/Tesla-Motors%2c-Inc----Teslive-2013

[ECole]

NBG -NIM remains among the highest among private sector peers even on a risk adjusted basis and core income growth was strong at 21% year-on-year





http://www.earningsimpact.com/Transcript/83078/NBG/National-Bank-of-Greece-SA---Q1-2013-Earnings-Call

[ECole]

Cereplast restructuring of global operation is expected to reduce annual operating expenses by $600,000 to $800,000 per year


http://www.earningsimpact.com/Transcript/82849/CERP/Cereplast%2c-Inc----Q2-2013-Earnings-Call/Page/3

[ECole]

Amarantus Presentation at OneMedForumNY-2013 was a good one.


Developing diagnostics and protein therapeutics for diseases associated with apoptosis, very specifically Parkinson's and Alzheimer's are lead applications.


http://www.earningsimpact.com/Transcript/83025/AMBS/Amarantus-BioSciences%2c-Inc---OneMedForumNY-2013

[ECole]

Amarin at Canaccord Conference says that we have a sales force throughout the United States of 275 reps in 27 different districts in four separate regions. We had started a cardiovascular outcome study a year ago and we now have that study up and running in 11 countries at over 400 sites, earlier this year we announced that we had over 4,000 patients already enrolled into that study, so that's going well.



http://www.earningsimpact.com/Transcript/82999/AMRN/Canaccord-Genuityandapos%3bs-33rd-Annual-Growth-Conference

[ECole]

Velti plc Earnings in Q2

advertising contributed approximately $8.9 million to total revenues, while mobile marketing revenues comprised the remaining



http://www.earningsimpact.com/Transcript/82961/VELT/Velti-plc---Q2-2013-Earnings-Call/Page/2

[ECole]

Cough observed to be the common adverse event in AFREZZA treated subjects.

Mannkind discusses more during business update call


http://www.earningsimpact.com/Transcript/82905/MNKD/Business-Update-Call

[ECole]

Qihoo 360 Technology Co. Ltd. Q2 2013 Earnings Call at 7.30 am ET today

[ECole]

Peregrine Pharma at Wedbush-2013-Life-Sciences-Management-Access-Conference

Have two Phase III ready clinical programs bavituximab which is their lead program, and Cotara program. They have FDA agreements for both of those compounds for Phase III trial designs.

http://www.earningsimpact.com/Transcript/82836/PPHM/Peregrine-Pharmaceuticals---Wedbush-2013-Life-Sciences-Management-Access-Conference